Temple Therapeutics: Funding, Investors & Team (Sep 2026)
Temple Therapeutics specializes in the creation and advancement of treatments for individuals suffering from orthopedic conditions, cancer, and endometriosis. Their primary focus lies in diseases characterized by abnormal tissue growth and malfunction, which often result in fibrosis, pain, infertility, and various forms of cancer.
Temple Therapeutics has raised $330k across 1 funding round on record, the most recent an undisclosed round of $330k announced in Dec 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Temple Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2023.
Temple Therapeutics Funding Rounds
Temple Therapeutics Founders and Leadership Team
Contact details for the Temple Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Temple Therapeutics Funding Compared to Other Biotechnology Startups
Temple Therapeutics' latest round of $330k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Temple Therapeutics in Biotechnology and Geleen
Companies Similar to Temple Therapeutics
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
Temple Therapeutics Funding FAQs
What does Temple Therapeutics do?
Temple Therapeutics specializes in the creation and advancement of treatments for individuals suffering from orthopedic conditions, cancer, and endometriosis. Their primary focus lies in diseases characterized by abnormal tissue growth and malfunction, which often result in fibrosis, pain, infertility, and various forms of cancer.
How much funding has Temple Therapeutics raised?
Temple Therapeutics has raised $330k across 1 round on record. The most recent is an undisclosed round of $330k announced in Dec 2023.
When did Temple Therapeutics last raise funding?
Temple Therapeutics' most recent funding round on record is an undisclosed round of $330k, announced in Dec 2023.
Who is the CEO of Temple Therapeutics?
Sanj Singh is listed as CEO at Temple Therapeutics.
Where is Temple Therapeutics headquartered?
Temple Therapeutics is based in Geleen, Limburg, Netherlands.
How many employees does Temple Therapeutics have?
Temple Therapeutics is in the 1-10 employee band.
How does Temple Therapeutics' funding compare to other Biotechnology startups?
Temple Therapeutics' latest round of $330k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Temple Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Temple Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.